Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amyris Fell 11% in September

TheMotleyFool

0 0

Shares of Amyris (NASDAQ: AMRS) fell 11% in September, according to data from S&P Global Market Intelligence, after it was accused in a lawsuit of patent infringement and misappropriating trade secrets.

Specialty ingredients biotech Amyris, which develops sustainable ingredients for the clean health and beauty markets, as well as for flavors and fragrances, started the month on a positive note after announcing it had successfully scaled up commercial production of cannabigerol (CBG), a molecule developed from Cannabis sativa L., or hemp.

Image source: Getty Images.

Source Fool.com

Like: 0

AMRS

Share